Advertisement
Singapore markets closed
  • Straits Times Index

    3,439.88
    +24.37 (+0.71%)
     
  • S&P 500

    5,537.02
    +28.01 (+0.51%)
     
  • Dow

    39,308.00
    -23.90 (-0.06%)
     
  • Nasdaq

    18,188.30
    +159.54 (+0.88%)
     
  • Bitcoin USD

    57,574.27
    -2,531.86 (-4.21%)
     
  • CMC Crypto 200

    1,209.52
    -51.66 (-4.10%)
     
  • FTSE 100

    8,250.55
    +79.43 (+0.97%)
     
  • Gold

    2,369.40
    0.00 (0.00%)
     
  • Crude Oil

    83.42
    -0.46 (-0.55%)
     
  • 10-Yr Bond

    4.3550
    -0.0810 (-1.83%)
     
  • Nikkei

    40,913.65
    +332.89 (+0.82%)
     
  • Hang Seng

    18,028.28
    +49.71 (+0.28%)
     
  • FTSE Bursa Malaysia

    1,616.75
    +1.43 (+0.09%)
     
  • Jakarta Composite Index

    7,220.89
    +24.13 (+0.34%)
     
  • PSE Index

    6,507.49
    +57.46 (+0.89%)
     

Hear from Dale Schwartz, Founder & CEO of Pinstripes Holdings Inc. Live at ICR Conference 2024

IPO Edge hosted a fireside chat at the 2024 ICR Conference with Dale Schwartz, Founder and CEO of Pinstripes Holdings Inc. (NYSE: PNST). The in-person interview was joined by Editor-at-Large Jarrett Banks and they discussed the distinctive features that make the company stand out against competitors, its recent experience of becoming a public company on the NYSE, the firm’s expansion plans, the company’s growth strategy and future trends for the entertainment and dining industry, and more. Watch the full recording below:

 

About Dale Schwartz

Mr. Schwartz has extensive experience in the formation, financing and expansion of various companies. In 2006, he founded Pinstripes, Inc. and is currently CEO of this unique bowling/bocce/bistro venture. In 2000, he was Co-Founder, Co-CEO of Pharmaca Integrative Pharmacy, Inc., a distinctive natural pharmacy retailer. From 1997 to 2000, Mr. Schwartz was Chief Executive Officer of Infigen, Inc., a private biotechnology company developing its proprietary nuclear transfer/cloning and genomic technologies. From 1991 to 1996, he was Chief Financial Officer of Ribozyme Pharmaceuticals, Inc., a biotechnology company commercializing its Nobel prize-winning genetic engineering technology. From 1987 to 1990, Mr. Schwartz was a Principal with Odyssey Partners, L.P., a private limited partnership engaged in leveraged buyouts, venture capital and recapitalizations. From 1983 to 1985, he was an Analyst in Morgan Stanley’s Mergers & Acquisitions department, and from 1979 to 1988 he was Founder and President of D & J Sealcoating, Inc., an asphalt sealcoating company. Mr. Schwartz has a Bachelor of Arts degree from Colgate University and a Masters in Business Administration from the Harvard Business School.

ADVERTISEMENT

About Pinstripes Holdings Inc.

Born in the Midwest, Pinstripes’ best-in-class venues offer a combination of made-from-scratch dining, bowling and bocce and flexible private event space. From its full-service Italian-American food and beverage menu to its gaming array of bowling and bocce, Pinstripes offers multi-generational activities seven days a week. Its elegant and spacious 25,000 – 38,000 square foot venues can accommodate groups of 20 to 1,500 people for private events, parties, and celebrations.

 

Contact:

IPO Edge

www.IPO-Edge.com

Editor@ipo-edge.com